July 26, 2023 — Tenax Therapeutics, Inc, a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced that the United States Patent and Trademark Office (USPTO) has granted a new method of use patent for oral levosimendan (TNX-103) in the treatment of pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF), expiring in 2040. 

July 26, 2023 —ŌNŌCOR LLC, a medical technology company dedicated to developing essential safety tools and other facilitating tech

July 25, 2023 — HeartFlow, Inc., the only non-invasive precision coronary care solution to provide both anatomic and physiologic insights, announced that new data on HeartFlow Plaque Analysis and its RoadMap Analysis will be presented at the 

July 25, 2023 — The Hypertension Center in the 

July 24, 2023 — Allegheny General Hospital (AGH), the flagship academic medical center of Allegheny Health Network (AHN), announced today it has once again received the Mitral Valve Repair Reference Center Award from the American Heart Association (AHA) and the Mitral Foundation for a demonstrated record of sup

July 24, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, announced that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal 

July 21, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i  announced that enrollment is complete in the SmartfIRE study designed to evaluate the safety and efficacy of its investigational

July 21, 2023 — Onecrea Medical has announced the success of the first-in-human implants of its Transcatheter Aortic Valve Replacement (TAVR) system for the treatment of aortic stenosis.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now